Forsiden ENOVA

ENOVA is a science and technology “Network on Vaccine Adjuvants”, funded by COST through the EU Framework Programme Horizon 2020. ENOVA is coordinated by the Vaccine Formulation Institute (UK) and brings together European experts and stakeholders working in different areas of adjuvant and vaccine R&D, including both prophylactic and therapeutic applications as well as human and veterinary vaccines.  ENOVA’s members include industry, academic, and government institutions. The ultimate goals of the network are to facilitate communication and the exchange of information among its membership, to ensure that new discoveries are widely disseminated so that their potential can be of optimal benefit, to promote the best use of existing adjuvant technologies, and to encourage and support the development of novel adjuvants.

Log in (restricted)

News

  • 5th Call for TRANSVAC Vaccine Development Services Mar. 6, 2019 7:48 AM

    TRANSVAC2 project offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. These services are not restricted to any disease in particular.

  • NEW DEADLINE: ENOVA Training School on “Immunoactive carbohydrates and adjuvants Feb. 27, 2019 1:56 PM

    We have a limited number of places left on the next ENOVA Training School on “Immunoactive carbohydrates and adjuvants: antibacterial vaccines from research to clinical trials” in Sienna which is running from the 2 nd to 4 th April. The deadline for applications has been extended to March 8th.

    The Training School is suitable for Ph.D. students and researchers who have a basic knowledge of analytical and organic chemistry and would like to increase their knowledge of vaccine development specifically in the area carbohydrate-based vaccines.

    https://www.enova-adjuvant.eu/training/

  • colourbox8759840 International meeting of the Spanish Society for Virology and the Global Virus Network Feb. 15, 2019 6:27 PM

    On behalf of the XV Congress of the Spanish Society of Virology ( Sociedad Española de Virología, SEV) Organizing Committee, it is my great pleasure to welcome you to Barcelona, Spain. The SEV congress will take place on June 9-12 th, 2019 at the Axa Auditorium located in one of the most modern areas of the city. More info here.

    For the first time, the SEV Congress will be organized together with the Global Virus Network (GVN), an international alliance of centers of excellence in the field of human and animal virology ( www.gvn.org); Dr. Christian Bréchot is the president of GVN. This collaboration will increase the scope of our well consolidated SEV Congress and its international visibility.

  • Tetrahedron prize for Creativiy Feb. 14, 2019 1:45 PM

    The Tetrahedron Prize for Creativity in Organic Chemistry was established in 1980 by the Executive Board of Editors and the Publisher of Tetrahedron Publications. It is intended to honour the memory of the founding co-Chairmen of these publications, Professor Sir Robert Robinson and Professor Robert Burns Woodward.

    Deadline for nomination is 31 march 2019

  • TRANSVAC2: “Infectious Diseases Models for Innovative Therapies” Jan. 30, 2019 11:21 AM

    The EU-funded project TRANSVAC2 and the “Infectious Diseases Models for Innovative Therapies” ( IDMIT) are pleased to invite you to a TRANSVAC workshop on “ In vivo imaging of host response to vaccines and infections” on 29 March 2019 at the IDMIT research infrastructure at the CEA center of Fontenay-aux-Roses (France). The workshop concentrates on latest advances in new technologies for imaging in living individuals.

Events

29 Mar.
Fontenay-aux-Roses (France)

The EU-funded project TRANSVAC2 and the “Infectious Diseases Models for Innovative Therapies” (IDMIT) are pleased to invite you to a TRANSVAC workshop on “In vivo imaging of host response to vaccines and infections” on 29 March 2019 at the IDMIT research infrastructure at the CEA center of Fontenay-aux-Roses (France). The workshop concentrates on latest advances in new technologies for imaging in living individuals. 

29 Mar.
Fontenay-aux-Roses (France)

The EU-funded project TRANSVAC2 and the “Infectious Diseases Models for Innovative Therapies” (IDMIT) are pleased to invite you to a TRANSVAC workshop on

In vivo imaging of host response to vaccines and infections” on 29 March 2019 at the IDMIT research infrastructure at the CEA center of Fontenay-aux-Roses (France). The workshop concentrates on latest advances in new technologies for imaging in living individuals.

This workshop is aimed to present the following topics:

1) Kinetics of vaccines distribution and persistence,

2) Pathogen penetration and dissemination,

3) Host response to vaccines and pathogens exposure.

02 Apr.

NEW deadline: Immunoactive carbohydrates and adjuvants: antibacterial vaccines, from research to clinical trials

2-4 April 2019, Siena, Italy, organised by University of Florence

 

We have a limited number of  places left on the next ENOVA Training School on “Immunoactive carbohydrates and adjuvants:   antibacterial vaccines from research to clinical trials” in Sienna which is running from the 2nd to 4th April.  The deadline for applications has been extended to March 8th.

The Training School is suitable for  Ph.D. students and researchers who have a basic knowledge of  analytical and organic chemistry and would like to increase their knowledge of vaccine development specifically in the area carbohydrate-based vaccines.  

https://www.enova-adjuvant.eu/training/